A new six intraperitoneal injection insulin-mimetic vanadyl(Ⅱ) compounds [(V
The expanding knowledge of the role of vanadium in biological systems and of the potential of vanadium compounds as therapeutic agents has led to a continuously increasing interest in the coordination chemistry and solution chemistry of this element[1]. Within the spectrum of vanadium complexes that have been synthesized as model compounds for the understanding of vanadium-controlled biological systems or as potential therapeutic agents with insulin-mimetic properties, one finds a substantial number of oxovanadium (Ⅴ ) chelate complexes with a variety of donor set[2]. Moreover, the discoveries of several medicinal properties of vanadium complexes viz., insulin-mimetic, anticancer, antitumour and antifungal/antibacterial activities[1, 2] have stimulated further research in this area. Diabetes mellitus was a serious metabolic disease that tendency to diseases and multiple-organ impairment[3]. The lacks of β -cells in the pancreas were the main cause of pathophysiological markers in the progress of both two types of diabetes either 1 or 2[4]. Therefore, the great therapeutic goal is to achieve the remarkable production and generation of pancreatic islets that would consequently ameliorate diabetes and reduced its complications[5]. Vitamin D3 (Fig.1) is synthesized in human skin on exposure to ultraviolet (UV) radiation from sunlight, or it can be obtained from food. Vitamin D has a well-known role as regulator of calcium homeostasis and is critical for bone mineralization[6]. In addition, vitamin D has been associated with various regulatory effects on the immune system[7]. Vitamin D deficiency in animals and humans produces defects in bone mineralization, such as rickets and osteomalacia, diseases characterized by an increase in osteoid and impaired calcium phosphate deposition[8]. An increased prevalence of diabetes has been described in Vitamin D deficient individuals[9]. This work aimed to synthesis and spectroscopic characterizations of new vanadyl(Ⅳ ) vitamin D3 complex, for the purpose of use as a treatment for diabetes, that induced by streptozotocin (STZ) in male albino rats.
All chemicals and solvents used in this investigation were of highest purity grade (Aldrich) and employed without further purifications. Vitamin D3 pure drug, vanadyl(Ⅱ ) sulfate and amino acids (isoleucine, threonine, proline, phenylalanine, lysine and glutamine as represented in were bought from Aldrich Company.
The solid vanadyl (Ⅳ )-vitamin D3-amino acid complexes with genaral formula [(V
The elemental analyses of %C, %H and %N contents were performed by the microanalysis unit using a Perkin Elmer CHN 2400 (USA). The vanadium metal content was determined gravimetrically by the direct ignition of the respected complexes at 800 ℃ for 3 hrs till constant weight. The residue was then weighted in the form of vanadium oxide. The molar conductivity of freshly prepared 1.0× 10-3 mol· cm-3 dimethylsulfoxide (DMSO) solution was measured for the dissolved vanadyl (Ⅳ ) vitamin D3 amino acid complexes using Jenway 4010 conductivity meter. The Solid reflectance spectra were measured on UV-3101 PC, Shimadzu, UV-Vis Spectrophotometer. The infrared spectra with KBr discs were recorded on a Bruker FT-IR Spectrophotometer (4 000~400 cm-1). Magnetic data were calculated using Magnetic Susceptibility Balance, Sherwood Scientific, Cambridge Science Park Cambridge, England, at Temp 25 ℃ in Cairo University. The electron spin resonance (ESR) spectra for vanadyl (Ⅳ ) vitamin D3 amino acid complexes were performed on Jeol, JES-FE2XG, ESR-spectrometer, Frequency 9.44 GHz with Jeol Microwave unit. The thermal study TG/DTG-50H was carried out on a Shimadzu thermogravimetric analyzer under nitrogen atmosphere till 800 ℃. Scanning electron microscopy (SEM) images were taken in Quanta FEG 250 equipment. The transmission electron microscopy images were performed using JEOL 100s microscopy. The X-ray diffraction patterns for the vanadyl (Ⅳ ) vitamin D3 amino acid complexes were recorded on X’ Pert PRO PANanalytical X-ray powder diffraction, target copper with secondary monochromate.
Male albino rats (weighing 100~120 g) were purchased from National Research Center in Cairo (Egypt). Animals were allowed free access to diet and water in good air conditioned room and were allowed free access and tap water for two weeks before starting the experiment. We have followed the European community Directive (86/609/EEC) and national rules on animal care. Animals were divided into four groups with 10 animals in each group as following:
Group (Ⅰ ): This served as normal control. Group (Ⅱ ): This untreated diabetic group (positive control) that was injected intraperitoneally (i.p) by a single dose of STZ (50 mg· kg-1 body weight)[10]. Group (Ⅲ ): This was injected i.p. with STZ (50 mg· kg-1 body weight) then injected each alternative day i.p. by vanadyl sulfate (Ⅳ ) alone at a dose of (40 mg· kg-1 body weight) for 30 days. Group (Ⅳ ): This was injected with STZ (50 mg· kg-1 body weight) and then injected each alternative day i.p. by vanadyl(Ⅳ ) vitamin D3 amino acid complexes (Ⅰ — Ⅵ ) at a dose of (40 mg· kg-1 body weight)[11] for 30 days.
Experimental diabetes was induced in 18 hrs fasted rats by single i.P. injection of STZ in a dose of 50 mg· k
The new six vanadyl(Ⅳ ) complexes which are synthesized in situ mixed ligands of vitamin D3 and amino acid chelates have higher melting point > 260 ℃, with yield 80%~85%. The microanalytical, physical and chemical formulas of these complexes are summarized in Table 1. This resulted data is in a good agreement with general formula of [(V
The electronic diffuse reflectance spectra of [(V
The ESR spectrum of the vanadyl(Ⅳ )/VD3/amino acid complexes were scanned in DMSO at room temperature and shown in Fig.2. The values of g‖ and g⊥ factors are matched with square pyramidal vanadyl complexes[20]. The g‖ , g⊥, A‖ and A⊥ values were calculated from the spectrum and the trend of g values calculated from the spectrum (g‖ < g⊥< 2), which are in good agreement for a square pyramidal structure.
The infrared spectra of VD3, amino acids and their mixed vanadyl(Ⅳ ) complexes are shown in Figs 3. The IR spectrum of vitamin D3 shows a very strong broad band at 3 418 cm-1 which assigned to ν (O— H) stretching vibration, ionization of the OH group with subsequent ligation through oxygen atom seems a plausible explanation. It is difficult to distinguish between the ν (OH) of free vitamin D3 and the stretching vibrational bands of water molecules of the complexes due to the overlapping between them values, and the appearance in one place[21]. The involvement of ν (OH) group of vitamin D3 in the coordination process can be approved by following the stretching vibration band of ν (C— O) in the complexes where the ν (C— O) is shifted to lower wavenumber from 1 049 cm-1 in case of free ligand to about 1 005~1 031 cm-1 in the prepared complexes with noticeable decrease in its intensity and this result indicates that the OH group is participated in the complexation[22] and vitamin D3 acts as monodentate ligand. Vitamin D3 shows a strong band at 1 451 cm-1 for the phenyl skeletal, this band shifted to lower frequency in the complexes to 1 414~1 418 cm-1 and this supporting the participation of OH group in the formation of the complexes. Vitamin D3 also shows two bands at 2 928 and 2 862 cm-1 due to the asymmetric and symmetric stretching vibrations of the CH2 and C
The XRD diffraction patterns of the [(VD3)(VO)(AA1)(H2O)] complex (Ⅰ ) (Fig.5) shows the presence of the characteristic peaks for vanadium (42.535° , 59.968° and 69.147° in accordance with JCPDS File 22-1058[26], vitamin D3 (6.377° , 20.427° , 21.355° , 23.616° , 25.491° , 28.099° , 30.727° , 49.281° , 50.981° , 53.223° , 56.605° , 63.910° , 65.591° and 66.905° )[27] and isoleucine (14.997° , 17.992° , 18.919° , 32.235° , and 32.989° , 34.109° , 36.544° ). The crystallite size of the vanadyl(Ⅳ ) VD3 complex can be calculated using Sherrer formula[28]. The calculation of particle size of the [(VD3)(VO)(AA1)(H2O)] complex from the highest line diffraction peak at 21.355° . XRD pattern of vanadyl(Ⅳ ) VD3 complex (Ⅰ ) has a nanocrystalline statement with ~20 nm size.
The distribution of the grain size is homogeneous complex, where medium to large particles size. According to TEM image (Fig.5), the particles of complex (Ⅰ ) exhibit regular spherical forms and their size is widely distributed ~20 nm.
It was clear from Table (2) that the intraperitoneally injection of vanadyl(Ⅳ ) sulfate alone and vitamin D3 complexes (Ⅰ — Ⅵ ) at a dose (40 mg· kg-1 body weight) each alternative day for 30 day significantly decreased the level of blood glucose of treated diabetic groups (positive control) specially group (Ⅳ 1) which injected by [(VD3)(VO)(AA1)(H2O)] complex that contain isoleucine amino acid where the blood glucose decreased by 54.74% compared to positive control group, so that this complex considered the more effective one. Our results demonstrate that the administration of vanadyl(Ⅳ ) sulfate and vitamin D3 complexes to diabetic rats at the same dose elicited a significant increase in insulin hormone level with respect to untreated diabetic (STZ) group where the injection retrieve the normal level of insulin hormone specially group (Ⅳ 1) which injected by [(VD3)(VO)(AA1)(H2O)] complex that contain isoleucine amino acid where the insulin increased by 51.89%[29].
Our results demonstrated that GPT activity increase in case of diabetic group and this increasing indicates that diabetes mellitus may induce hepatic dysfunction in streptozotocin (STZ) induced diabetic rats; hence restoration of normal level of this enzyme indicates normal functioning of liver under effect of treatment[30]. These results corroborate those of other authors who also reported increased GPT in induced diabetic rats by a single dose of STZ given intraperitoneally. The injection of vanadyl(Ⅳ ) sulfate alone at dose (40 mg· kg-1 body weight) slightly increase the activity of GPT enzyme by 10.30% with respect to diabetic group, while the injection of vitamin D3 complexes at the same dose slightly decrease the serum GPT activity specially [(VD3)(VO)(AA2)(H2O)] complex that contain threonine amino acid where the GPT activity decreased by 13.59% compared to diabetic group and 22.50% compared to vanadyl(Ⅳ ) sulfate alone at the same dose. These results indicate that the treatment with vitamin D3 vanadyl(Ⅳ ) amino acids complexes have low side effect and toxicity on liver cells of diabetic rats compared with vanadyl(Ⅳ ) sulfate alone[30].
Our results as shown in Table 2, the treatment of diabetic rats with only vanadyl(Ⅳ ) sulfate and vitamin D3 complexes have a good effect in decreasing the creatinine level specially [(VD3)(VO)(AA5)(H2O)]· 2H2O complex that contain lysine amino acid where the creatinine level decreased by 46.49% compared to diabetic (STZ) rats and thus indicating that vitamin D3 complexes have no side effect on kidneys tissue and greatly improve the kidney function. The increased value of uric acid that was observed in diabetic rats is coinciding with Edwards[31, 32] who found that the uric acid increased in diabetic mice and this may be due to breaking down of uric acid in diabetics to substances that called purines. According to our study the value of uric acid was decreased in treatment of diabetic rats with vitamin D3 complexes specially [(VD3)(VO)(AA5)(H2O)]· 2H2O complex that contain lysine amino acid where the uric acid decreased by 25.88% compared with diabetic positive control group and this reduction in uric acid can explain due to the inhibited oxidative phosphorylation processes which leading to a decrease of protein synthesis.
The activity of LDH enzyme in different experimental groups is presented in Table 2. In general the activity of serum LDH in STZ diabetic rats was significantly increased compared to normal control group and this is mainly due to the leakage of LDH into the blood because of STZ toxicity in the liver. The administration of vanadyl sulfate alone at a dose (40 mg· kg-1 body weight) each alternative day increase the activity of LDH by 5.78% compared with the diabetic positive control group while the administration of vitamin D3 complexes at the same dose elicited a significant decrease in the activities of LDH compared to diabetic positive control group specially group Ⅳ 4 that injected by [(VD3)(VO)(AA4)(H2O)]· 5H2O complex which contain phenylalanine amino acid where this complex afforded a significant decrease in LDH by 11.94%, and this reflects the ameliorative role of vanadyl(Ⅳ ) complexation with vitamin D3 and amino acids in reducing the tissue damage that caused by diabetes[33]. G6PD is the principal source of the major intracellular reductant, NADPH, which is required by many enzymes, including enzymes of the antioxidant pathway[34]. G6PD deficiency is a hereditary condition in which red blood cells breakdown when the body is exposed to certain drugs or the stress of infection. Our study demonstrate that the activity of G6PD was decreased in all STZ diabetic rats as compared to normal control (Table 2), the same observations have been reported previously[35]. The treatment of diabetic STZ rats with vitamin D3 complexes significantly increased the G6PD activity as compared to positive diabetic group especially group Ⅳ 6 that injected by [(VD3)(VO)(AA6)(H2O)] complex which contain glutamine amino acid where the G6PD activity increased by 30.34%. This results concerning the significant effect of vanadyl(Ⅳ ) complexation with vitamin D3 and amino acids on G6PD level.
Our obtained results Table 2 revealed that the diabetic untreated group (STZ) afforded a highly considerable decline in Hb content with respect to the normal controller group and this reduction is mainly due to the reduction in insulin level, where insulin generally enhances the anabolic effect of protein which may be responsible for the decreasing level of Hb in diabetic animals[36]. The treatment of diabetic rats with vitamin D3 complexes elicited a significant increasing in Hb content in comparison with untreated STZ diabetic rats at the end of the study specially [(VD3)(VO)(AA3)(H2O)]· 6H2O complex that contain proline amino acid where Hb increased by 20.14%, and this a sign on low toxicity effect of vitamin D3 complexes on living system of experiment animals.
The efficiency of vitamin D3 complexes on the treatment of diabetic STZ rats recorded a slight decreasing in SOD level compared with the normal controller group. It was clear from Table 2, that the level of SOD in STZ diabetic rats treated with VO(Ⅳ ) complexes specially group (Ⅳ 1) which injected by [(VD3)(VO)(AA1)( H2O)] complex that contain isoleucine amino acid only decreased by 3.27% compared to normal group. The reduced activity of SOD could be due to its degradation or inhibition as a result of the increased production of free radicals in diabetes mellitus[37]. The treatment with vitamin D3 complexes increased the activity of SOD and may help in controlling free radicals in diabetic rats.
It was apparent from Table 2 that there were a significant increase in the levels of serum triglycerides, total cholesterol, LDL-c in diabetic untreated STZ rats but there were marked reduction in HDL-c in STZ diabetic rats, the main cause for this marked increment of serum lipids in diabetic rats is mainly as a result of increasing the free fatty acids mobilization from the peripheral deposits, since insulin inhibits the hormone sensitive lipase[38]. Excess fatty acids in the serum of diabetic rats are converted into phospholipids and cholesterol in the liver. Liver, an insulin dependent tissue that plays a pivotal role in glucose and lipid homeostasis and it is severely affected during diabetes. Diabetes results in decrease in glucose utilization and an increase in glucose production in insulin-dependent tissues, such as liver. It was clear from the present study that the administration of vitamin D3 complexes at a dose (40 mg· kg-1 body weight) led to significant improvement in the lipid parameters specially the administration of [(VD3)(VO)(AA1)(H2O)] complex that contain isoleucine amino acid where total cholesterol (TC), triglycerides (TG) and LDL-c are significantly decreased by 46.05%, 34.47% and 30.41% respectively while HDL-c level is significantly increased by 42.22% in the serum of diabetic rats compared with positive control diabetic group. These results go in head to head with Toshio et al.[39] who reported that vanadium salts have great role in stimulating the release of lipoprotein lipase (LPL) especially in combination with adenosine and these findings are greatly agreed with our results. Lipoprotein lipase (LPL) catalyzes the hydrolysis of plasma triglycerides and thereby regulate the uptake of fatty acids by tissues as adipose tissues, skeletal muscles and cardiac muscles and this explain the significant increase of serum lipid parameters in diabetic untreated rats and the role of vitamin D3 VO(Ⅳ ) complex in ameliorating lipid profile picture and decreasing these parameters. Our results are also greatly agreed with [40] who clarified that daily oral administration of sodium metavanadate to STZ diabetic rats induced normalization of blood glucose and triglycerides levels, so all these findings suggested that vanadate salts can treat and reduce the hypertriglyceridemia that occurred during diabetes and this occurs through stimulating the secretion of LPL from adipose tissues. All these previous studies reinforced our results as the complexation between vitamin D3 and vanadyl sulfate has greatly succeeded in reverting high values of triglycerides and cholesterol levels induced by STZ to nearly normal values.
The cells of the pancreas from normal control group were all present in their normal proportions and showing normal structure consisting of normal pancreatic tissue and normal sized islet of langerhans surrounded by normal pancreatic acini. The islets contain alpha cells secreting glucagon and beta cells secreting insulin as shown in Fig.6. On the other hand, pancreatic tissues in STZ diabetic control rats showing dilated congested vascular spaces surrounded by aggregates of inflammatory cells and pancreatic acini. The islets are largely occupied by a uniform eosinophilic material and few atrophic cells with reduction in its size. Eosinophilic materials also surround the blood vessel as shown in Fig. 6. Pancreatic tissues in diabetic rat treated with only VOSO4 showing mild improvement of the size of islet of langerhans with dilated congested vascular space surrounded by few aggregates of inflammatory cells as shown in Fig.6. Pancreatic tissues in diabetic rat treated with vitamin D3/vanadyl/isoleucine system complex [(VD3)(VO)(AA1)(H2O)] showed showing a good response with return of islet of langerhans to its normal size and absence of inflammatory cell and no eosinophilic deposits were seen as shown in Fig.6. In the present study the histopathological of pancreas of normal control rats did not show any notable changes in its histology throughout the 30 days study. In contrast, STZ administration elicited severe injury to pancreas, leading to decrease in the islet cell numbers and in the diameter of pancreatic islets where the islets were shrunken in diabetic rats when compared with normal rats. This destruction of the islets leads to an absolute lack of insulin that characterizes diabetes mellitus. The administration of VOSO4 showing mild expansion of islets and significantly reduced the injuries to pancreas within 30 days of treatment and recover the damage of pancreatic tissue. The treatment of the diabetic rats with vanadyl complexes specially [(VD3)(VO)(AA1)(H2O)] complex return the normal pancreas histological structure with rich vascular supply and this may be due to the role of the prepared complexes in recovering the damage of pancreatic tissue that caused by STZ-induced diabetes. In conclusion, this study investigated the effect of STZ on a β cells and threw light on the potential of vanadyl complexes in the prevention or treatment of diabetes.
Microscopically, liver from normal control group showed normal structure consisting of the central vein surrounded by rows and cords of healthy hepatocytes with central nucleus and blood sinusoids as shown in Fig.7. On the other hand, Liver tissues in diabetic control rats showed a large area of hepatic necrosis infiltrated with inflammatory cells with markedly dilated congested central vein filled with red blood cells and surrounded by aggregates of inflammatory cells with rows and cords of swelled and degenerated hepatocytes with sever fatty change as shown in Fig.7. Liver tissues in diabetic rat treated with only VOSO4 showed mild improvement of hepatocytes with moderately dilated congested central vein surrounded by rows and cords of hepatocytes showing moderate degree of fatty change with normal parenchymal histology as shown in Fig.7. Liver tissues in diabetic rat treated with vitamin D3/vanadyl/isoleucine system complex [(VD3)(VO)(AA1)(H2O)] showed good improvement of the liver tissues and return to the normal state with normal size of central vein surrounded by rows and cords of normal hepatocytes and absence of inflammatory cells as shown in Fig.7. In the current study, the results showed that, treatment of the diabetic rats with vanadyl complexes specially [(VD3)(VO)(AA1)(H2O)] complex return the normal liver histological structure and this may be due to the role of the prepared complexes in diminishing the oxidative stress on hepatic cells and diminishing hepatocellular damage and suppression of gluconeogenesis and consequently may alleviate liver damage caused by STZ-induced diabetes. These results are in agreement with those obtained by Subash et al.[41] as they studied the same effect of cinnamaldehyde on liver tissues.